Johnson & Johnson (NYSE:JNJ)

ThinkstockPhotos-464526524

The 4 Stocks That Tanked the Dow on Friday

February 5, 2016: Markets opened lower on Friday following a lower-than-expected report on nonfarm payrolls. There appears to be some concern that investors are worried about the impact of the ...
Read Full Story »
Money close-up

Johnson & Johnson Kicks Off 2016 With Solid Earnings and Guidance

Johnson & Johnson (NYSE: JNJ) reported its fourth-quarter financial results before the markets opened on Tuesday. The company posted $1.44 in earnings per share (EPS) on $17.8 billion in revenue, ...
Read Full Story »
Johnson & Johnson logo

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson (NYSE: JNJ) is set to release its fourth-quarter financial results before the markets open Tuesday. Thomson Reuters has consensus estimates of $1.42 in earnings per share (EPS) ...
Read Full Story »
Profit or Loss

Top DJIA Earnings for the Week Ahead

Earnings season for the fourth quarter of last year has ramped up, and 24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies ...
Read Full Story »
buy sell stocks

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors have moved from buying every pullback, a pattern that had not been interrupted once from 2011 to 2014, to a mentality of selling each market rally. On last look, ...
Read Full Story »
Medical interface

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

Johnson & Johnson (NYSE: JNJ) is looking to save some money over the next few years and as a result it is taking action by restructuring its Medical Devices businesses. ...
Read Full Story »
Prescription drugs

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Now that 2015 has ended, 24/7 Wall St. wanted to see what the strategists and analysts on Wall Street expect for the stock market in 2016. It turns out the ...
Read Full Story »

The 10 Most Profitable Companies in the World

In the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not limited to the United States, although many of the world's ...
Read Full Story »
Medicine pills

Janssen Secures Approval From FDA on New LPS and LMS Drug

Janssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received ...
Read Full Story »
Quotes

The 4 Stocks That Dominated the Dow on Thursday

October 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech stocks continue to get new life, helping overcome some softness ...
Read Full Story »
Money background. Close-up.

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2015 results before markets opened Tuesday. The health care giant reported quarterly adjusted diluted earnings per share (EPS) of $1.49 on revenue of ...
Read Full Story »
JNJOffice

What to Expect From Johnson & Johnson Earnings

Johnson & Johnson (NYSE: JNJ) is scheduled to report its third-quarter financial results before the markets open on Tuesday. The consensus estimates from Thomson Reuters call for $1.45 in earnings ...
Read Full Story »
Wall Street/NYSE

Top Dow Earnings in the Coming Week

Earnings season for the third quarter of the calendar year has kicked off, and 24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AutoZone, Discover, IBM, Microsoft, Twitter, Viacom, Wynn and Many More

Stocks were indicated higher on Monday, showing that the trend of buying the dips and the sell-offs after four years has not died. 24/7 Wall St. reviews dozens of analyst ...
Read Full Story »
generic drugs

Achillion Pharma Rises on Solid Interim Results

Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) is making up for lost time with its most recent news. Over the course of 2015 and last year, the stock has suffered, but it ...
Read Full Story »